$0.9705
-0.0097[-0.99%]
At close: May 30
$0.9705
0[0.00%]
After Hours: 7:57PM EDT
Biodexa Pharmaceuticals
(NASDAQ:BDRX)Latest News for Biodexa Pharmaceuticals Stock (NASDAQ:BDRX)
Biodexa Pharmaceuticals Stock (NASDAQ: BDRX)
Categories: All
Tuesday, May 28, 2024
Wednesday, May 22, 2024
- Nasdaq Falls Over 100 Points; TJX Posts Upbeat Q1 ResultsAvi Kapoor - May 22, 2024, 2:32PM
- Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - May 22, 2024, 1:27PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - May 22, 2024, 12:31PM
- Gold Down Over 1%; Williams-Sonoma Posts Strong EarningsAvi Kapoor - May 22, 2024, 12:17PM
- US Stocks Mixed; Target Posts Downbeat EarningsAvi Kapoor - May 22, 2024, 9:55AM
- Biodexa Pharmaceuticals Stock Is Tumbling Wednesday: What's Going On?Adam Eckert - May 22, 2024, 9:31AM
- Biodexa shares are trading lower after the company announced $7 million of gross proceeds from warrant exercises.Benzinga Newsdesk - May 22, 2024, 8:35AM
- Biodexa Announces $7M Of Gross Proceeds From Warrant Exercises And An Agreement Between The Company And Several Accredited Investors To Exercise Certain Existing Series E Warrants And Series F Warrants To Purchase Up To An Aggregate Of 4,358,322 ADSsBenzinga Newsdesk - May 22, 2024, 8:33AM
Tuesday, May 21, 2024
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga Insights - May 21, 2024, 4:31PM
- Gold Moves Lower; Macy's Boosts 2024 ForecastAvi Kapoor - May 21, 2024, 2:46PM
- Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - May 21, 2024, 1:36PM
- Biodexa Pharmaceuticals shares are trading higher after the company presented statistically significant Phase 2 results of eRapa.Benzinga Newsdesk - May 21, 2024, 1:10PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - May 21, 2024, 12:31PM
- Crude Oil Moves Lower; Lowe's Earnings Top ViewsAvi Kapoor - May 21, 2024, 12:00PM
- What's Going On With Biodexa Pharmaceuticals Stock?Dylan Berman - May 21, 2024, 10:45AM
- US Stocks Mixed; Zoom Video Posts Upbeat EarningsAvi Kapoor - May 21, 2024, 10:03AM
- Market-Moving News for May 21stBenzinga Newsdesk - May 21, 2024, 8:42AM
- Biodexa Pharmaceuticals Presents Phase 2 Clinical Trial Results Of Its Newly-Licensed eRapa In Familial Adenomatous Polyposis Scheduled For Presentation At The 2024 Digestive Disease Week Annual Meeting; Reports Overall 83% Non-Progression Rate At 6 MonthsBenzinga Newsdesk - May 21, 2024, 8:38AM
- Why Larimar Therapeutics Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving PremarketAvi Kapoor - May 21, 2024, 8:12AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - May 21, 2024, 8:06AM
Monday, April 29, 2024
Friday, April 26, 2024
- Dow Surges Over 200 Points; Microsoft Shares Gain Following Upbeat EarningsAvi Kapoor - Apr 26, 2024, 2:50PM
- Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Apr 26, 2024, 1:56PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Apr 26, 2024, 12:31PM
- S&P 500 Gains 1%; Exxon Mobil Posts Downbeat EarningsAvi Kapoor - Apr 26, 2024, 12:06PM
- US Stocks Higher Following PCE Inflation Data; Nasdaq Jumps Over 200 PointsAvi Kapoor - Apr 26, 2024, 9:54AM
- Biodexa Pharmaceuticals Shares Resume TradeBenzinga Newsdesk - Apr 26, 2024, 9:38AM
- Biodexa Pharmaceuticals Shares Halted On Circuit Breaker To The Downside, Stock Now Up 104.2%Benzinga Newsdesk - Apr 26, 2024, 9:33AM
- Biodexa shares are trading higher after the company entered an exclusive license agreement with Rapamycin Holdings for the rights to eRapa.Benzinga Newsdesk - Apr 26, 2024, 8:36AM
- Biodexa Enters Into Exclusive License To eRapa, A Phase 3 Ready Asset For The Treatment Of Familial Adenomatous Polyposis; Worldwide Rights Come With $17M In Non-Dilutive Grant Funding For Pivotal Phase 3 Trial In FAPBenzinga Newsdesk - Apr 26, 2024, 8:34AM
Friday, April 19, 2024
- Biodexa Pharmaceuticals Sees Prelim. FY23 EPS £(0.02)Benzinga Newsdesk - Apr 19, 2024, 8:14AM
- Biodexa Pharmaceuticals Says We Have The Resources To Deliver Two Sets Of Preclinical Data And Three Sets Of Clinical Data In 2024; Our Development Pipeline Now Includes Five Programs, Of Which Four Are At Clinical Stage; With Pipeline Stronger Than It Has Ever Been, We Are Enthusiastic About The Potential For Our Company In 2024 And Beyond.Benzinga Newsdesk - Apr 19, 2024, 8:09AM
- Biodexa Pharmaceuticals Sees Prelim. FY23 Revenue £0.38MBenzinga Newsdesk - Apr 19, 2024, 8:07AM
Wednesday, April 03, 2024
Friday, March 29, 2024
Thursday, March 28, 2024
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Mar 28, 2024, 4:31PM
- Crude Oil Surges Over 2%; MSC Industrial Shares Fall After Q2 ResultsAvi Kapoor - Mar 28, 2024, 2:56PM
- Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Mar 28, 2024, 2:08PM
- Extend Life Expectancy Against Aggressive Brain Cancers - Nano-Cap Firm Biodexa's Investigational Drug Shows PotentialVandana Singh - Mar 28, 2024, 12:43PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Mar 28, 2024, 12:31PM
- Gold Gains 1%; Walgreens Narrows Earnings ForecastAvi Kapoor - Mar 28, 2024, 12:30PM
- US Stocks Flat; Initial Jobless Claims Fall To 210,000Avi Kapoor - Mar 28, 2024, 10:32AM
- Market-Moving News for March 28thBenzinga Newsdesk - Mar 28, 2024, 8:36AM
- Biodexa's MTX110 Shows Promise In Extending Life Expectancy Against Aggressive Brain Cancers; Shares Spike HigherBenzinga Newsdesk - Mar 28, 2024, 8:19AM